OverviewChartNewsTraderScreen

Citi Knock-Out LLY/  DE000KH5GRX0  /

Frankfurt Zert./CITI
02/08/2024  19:32:21 Chg.-3.640 Bid21:59:34 Ask- Underlying Strike price Expiration date Option type
33.740EUR -9.74% -
Bid Size: -		 -
Ask Size: -		 Eli Lilly and Co 428.6776 USD 31/12/2078 Call
TeleTrader 08/08 US opens higher with data, earnings in focus
TeleTrader 08/08 Eli Lilly's Q2 revenue jumps 36% to $11.3B
TeleTrader 08/07 Eli Lilly launches $3.2B tender offer for Morphic
TeleTrader 02/07 US FDA approves Eli Lilly's Alzheimer's drug
GlobeNewswire 01/07 Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studyi...
GlobeNewswire 28/06 Atossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combin...
TeleTrader 25/06 Lilly partners with OpenAI to combat drug-resistance bacteria
GlobeNewswire 21/06 HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by Takeda
GlobeNewswire 17/06 CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer
GlobeNewswire 17/06 Atossa Set to Join Russell 3000® Index Effective June 28, 2024
GlobeNewswire 14/06 TScan Therapeutics Announces Updates to its Board of Directors
GlobeNewswire 11/06 Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D ...
TeleTrader 10/06 FDA advisors endorse Eli Lilly's Alzheimer's drug
GlobeNewswire 10/06 Sermonix Pharmaceuticals Announces Breast Cancer Research Publication of Paper Examining Lasofoxifen...
GlobeNewswire 06/06 Sermonix Pharmaceuticals Announces Chinese Approval of Investigational New Drug Application for Laso...
TeleTrader 05/06 Alphabet appoints Anat Ashkenazi as new CFO
GlobeNewswire 03/06 HUTCHMED Highlights Publication of Phase III FRUTIGA Results in Nature Medicine
GlobeNewswire 30/05 Sermonix Pharmaceuticals to Present Poster on ELAINE-3 Trial in Progress at ASCO 2024
GlobeNewswire 30/05 Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More
GlobeNewswire 24/05 Gov. Holcomb Joins Lilly to Announce Additional $5.3 Billion Investment at LEAP District
TeleTrader 24/05 Eli Lilly to reveal $5.3B production boost
TeleTrader 21/05 Eli Lilly's diabetes drug receives authorization in China
GlobeNewswire 16/05 BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...
GlobeNewswire 16/05 Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly
GlobeNewswire 13/05 Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update